Cognigen Corporation And Bristol-Myers Squibb Team Up To Bring e-Strategies To Drug Development
Partnership will Facilitate Exchange and Review of Data During U.S. Food and Drug Administration (FDA) Application Process
28-Oct-2000 -
BUFFALO, NEW YORK (October 24, 2000) -- Cognigen Corporation, a
global analytical communication company, today announced an Internet-based
collaboration with Bristol-Myers Squibb Company (NYSE: BMY) that is
expected to reduce the timeline for drug development.
Through a significant ...
anti-infectives
Bristol-Myers Squibb
clinical trials
+10